Literature DB >> 27392089

Neural Correlates of Response Inhibition in Adolescents Prospectively Predict Regular Tobacco Smoking.

Andrey P Anokhin1, Simon Golosheykin1.   

Abstract

Inhibitory deficits have been widely reported in addiction; however, it remains unclear whether such deficits represent a determinant or a consequence of substance use. Here we show, using a prospective longitudinal design, that developmental abnormalities in the neural correlates of response inhibition in adolescents increase the risk for subsequent cigarette smoking. Reduced No-Go P3 amplitude, delayed latency of Go P3 peak, and reduced synchrony of neuronal oscillations at age 14 prospectively predicted regular smoking at age 18. The present findings suggest that functional brain correlates of response inhibition represent a developmental marker of risk for future substance abuse.

Entities:  

Mesh:

Year:  2016        PMID: 27392089      PMCID: PMC4993600          DOI: 10.1080/87565641.2016.1195833

Source DB:  PubMed          Journal:  Dev Neuropsychol        ISSN: 1532-6942            Impact factor:   2.253


  73 in total

Review 1.  Estimating two-stage models for genetic influences on alcohol, tobacco or drug use initiation and dependence vulnerability in twin and family data.

Authors:  Andrew C Heath; Nicholas G Martin; Michael T Lynskey; Alexandre A Todorov; Pamela A F Madden
Journal:  Twin Res       Date:  2002-04

Review 2.  Adolescent brain development, risk-taking and vulnerability to addiction.

Authors:  Jacques Dayan; Alix Bernard; Bertrand Olliac; Anne-Sophie Mailhes; Solenn Kermarrec
Journal:  J Physiol Paris       Date:  2010-09-08

Review 3.  Event-related phase reorganization may explain evoked neural dynamics.

Authors:  Wolfgang Klimesch; Paul Sauseng; Simon Hanslmayr; Walter Gruber; Roman Freunberger
Journal:  Neurosci Biobehav Rev       Date:  2007-04-13       Impact factor: 8.989

4.  The adolescent brain.

Authors:  B J Casey; Sarah Getz; Adriana Galvan
Journal:  Dev Rev       Date:  2008

5.  Differences in "bottom-up" and "top-down" neural activity in current and former cigarette smokers: Evidence for neural substrates which may promote nicotine abstinence through increased cognitive control.

Authors:  Liam Nestor; Ella McCabe; Jennifer Jones; Luke Clancy; Hugh Garavan
Journal:  Neuroimage       Date:  2011-04-01       Impact factor: 6.556

6.  A solution for reliable and valid reduction of ocular artifacts, applied to the P300 ERP.

Authors:  H V Semlitsch; P Anderer; P Schuster; O Presslich
Journal:  Psychophysiology       Date:  1986-11       Impact factor: 4.016

7.  Cigarette smoking in a student sample: neurocognitive and clinical correlates.

Authors:  Wayne M Dinn; Ayse Aycicegi; Catherine L Harris
Journal:  Addict Behav       Date:  2004-01       Impact factor: 3.913

8.  Impulsiveness and ERP components in a Go/Nogo task.

Authors:  Martin Ruchsow; Georg Groen; Markus Kiefer; Leopold Hermle; Manfred Spitzer; Michael Falkenstein
Journal:  J Neural Transm (Vienna)       Date:  2008-03-27       Impact factor: 3.575

9.  Delta, theta, and alpha event-related oscillations in alcoholics during Go/NoGo task: Neurocognitive deficits in execution, inhibition, and attention processing.

Authors:  Ashwini K Pandey; Chella Kamarajan; Niklas Manz; David B Chorlian; Arthur Stimus; Bernice Porjesz
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2015-10-09       Impact factor: 5.067

Review 10.  Functional brain imaging across development.

Authors:  Katya Rubia
Journal:  Eur Child Adolesc Psychiatry       Date:  2012-06-24       Impact factor: 4.785

View more
  8 in total

Review 1.  The intersection between response inhibition and substance use among adolescents.

Authors:  Kristine Rømer Thomsen; Tine Blom Osterland; Morten Hesse; Sarah W Feldstein Ewing
Journal:  Addict Behav       Date:  2017-11-29       Impact factor: 3.913

Review 2.  Cognitive Dysfunction, Affective States, and Vulnerability to Nicotine Addiction: A Multifactorial Perspective.

Authors:  Morgane Besson; Benoît Forget
Journal:  Front Psychiatry       Date:  2016-09-21       Impact factor: 4.157

3.  Effects of environmental tobacco smoke exposure on brain functioning in never-smoking adolescents.

Authors:  Joyce Dieleman; Marloes Kleinjan; Roy Otten; Hein T van Schie; Vivian Heuvelmans; Maartje Luijten
Journal:  Brain Behav       Date:  2020-07-01       Impact factor: 2.708

4.  Test-Retest Reliability of Neural Correlates of Response Inhibition and Error Monitoring: An fMRI Study of a Stop-Signal Task.

Authors:  Ozlem Korucuoglu; Michael P Harms; Serguei V Astafiev; Semyon Golosheykin; James T Kennedy; Deanna M Barch; Andrey P Anokhin
Journal:  Front Neurosci       Date:  2021-01-28       Impact factor: 4.677

5.  Using multivariate endophenotypes to identify psychophysiological mechanisms associated with polygenic scores for substance use, schizophrenia, and education attainment.

Authors:  Jeremy Harper; Mengzhen Liu; Stephen M Malone; Matt McGue; William G Iacono; Scott I Vrieze
Journal:  Psychol Med       Date:  2021-03-18       Impact factor: 10.592

6.  Changes in inhibitory control, craving and affect after yoga vs. aerobic exercise among smokers with nicotine dependence.

Authors:  Hyungsook Kim; Jingu Kim; Minjung Woo; Teri Kim
Journal:  Front Psychiatry       Date:  2022-07-15       Impact factor: 5.435

Review 7.  The utility of twins in developmental cognitive neuroscience research: How twins strengthen the ABCD research design.

Authors:  William G Iacono; Andrew C Heath; John K Hewitt; Michael C Neale; Marie T Banich; Monica M Luciana; Pamela A Madden; Deanna M Barch; James M Bjork
Journal:  Dev Cogn Neurosci       Date:  2017-09-12       Impact factor: 6.464

8.  Testing the association between tobacco and cannabis use and cognitive functioning: Findings from an observational and Mendelian randomization study.

Authors:  Liam Mahedy; Robyn Wootton; Steph Suddell; Caroline Skirrow; Matt Field; Jon Heron; Matthew Hickman; Marcus R Munafò
Journal:  Drug Alcohol Depend       Date:  2021-02-12       Impact factor: 4.492

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.